Epidemic keratoconjunctivitis is usually caused by infection with an adenovirus, generally type 8 (Hanna, Jawetz, Mitsui, Thygeson, Kimura, and Nicholas, I957). As this is a DNA virus it might be expected to respond to treatment with 5-iodo-2'-deoxyuridine (IDU) which acts by interfering with the normal synthesis of DNA, thus preventing replication of DNA-containing viruses (Herrmann, I 96 I; Smith, I963). It has now been shown that IDU is effective in the treatment of acute infections of the eye due to the DNA virus herpes simplex (Kaufman, I962; Patterson, Fox, Davies, Maguire, Holmes Sellors, Wright, Rice, Cobb, and Jones, I963). The present study was designed to determine whether IDU applied locally in ointment form to the eyes of out-patients was of value in the treatment of epidemic keratoconjunctivitis associated with adenovirus infection.
The patients comprised seventy consecutive cases of acute follicular conjunctivitis, with symptoms of less than 4 days' duration, who were referred to the Glasgow Eye Infirmary Out-patient Department during the course of an epidemic affecting the Clydeside area in the winter of 1967-68. At each visit the presence or absence and severity of the following clinical features was noted: foreignbody sensation, tearing, burning sensation, blurring of vision, conjunctival injection, follicles, chemosis, pseudo-membrane, keratitis, corneal opacities, keratic precipitates, lid oedema, and preauricular lymphadenopathy. Visual acuity was also recorded. The patients were treated as outpatients either (a) with o 5 per cent. IDU made up in ointment form or (b) with the ointment base alone. The treatment was allocated in a random fashion, both patient and doctor being unaware which regime was being used. Treatment was carried out for one week, the ointment being used at 3-hrly intervals during the day and 6-hrly at night. Special emphasis was made to the patients of the need to adhere strictly to the regime of treatment. Progress was assessed at regular weekly intervals until symptoms had completely subsided and there were no signs of active keratoconjunctivitis usually from 3 to 6 weeks.
For virus isolation, conjunctival scrapings were collected at the initial interview and again one week later and placed in virus transport medium (Grist, Ross, Bell, and Stott, i966) . Paired sera were taken for virus serological tests, the first specimen at the initial visit and the second specimen two weeks later. Virological tests were carried out as described by Bell, Martin, and Ross (i969) .
Results
The results of virus isolation from the initial specimens from the seventy patients are shown in Table I A follow-up study was carried out 4 months later when eleven treated cases (8 of adenovirus 8 infection) and ten controls (6 of adenovirus 8 infection) attended for review. No patient had sustained any recurrence of symptoms, and there had been no appreciable alteration in the density or number of any sub-epithelial corneal opacities present.
Cases without virological evidence of infection
Of the 33 patients in whom no virological evidence of infection was found, five developed a punctate epithelial keratitis (i treated and 4 controls). The remaining 28 cases (i6 treated and 12 controls) showed no evidence of corneal damage apart from one control patient who developed a corneal abrasion. All 28 made a complete recovery within 2 weeks.
Discussion
Assessment of IDU therapy in epidemic keratoconjunctivitis has mainly been carried out by clinical criteria alone without virological studies (Scullica, I962; Imre, Korchmairos, Nasz, and Kulcsar, I964; Marre, I964). Virological investigations were carried out in a study by Hecht, Hanna, Sery, and Jawetz (I965), who found that IDU had no beneficial effect; however, treatment was delayed until the onset of keratitis. Obviously true assessment of IDU in epidemic keratoconjunctivitis can best be made where virological tests have demonstrated infection with a DNA virus such as adenovirus or herpes simplex, and where treatment has been instituted during the phase of active virus proliferation. In the present trial treatment was attempted on an out-patient basis as we were dealing with an epidemic situation where individual hospitalization was not possible. Ointment was used in preference to drops as it was felt that in this way patients were more likely to adhere to the treatment schedule, and thus a more constant local concentration of the drug would be achieved. Treatment was instituted in all cases before the onset of keratitis. With this regime no beneficial effect of IDU was detected in patients with adenovirus infections of the eye. Despite the institution of treatment early in the course of the disease there was no evidence that the drug produced any reduction in the prevalence or severity of the keratitis. The adenovirus infections appeared to run their natural course uninfluenced by the presence of IDU. It is possible that more intensive in-patient treatment might have achieved better results, although this is unlikely in view of the absence of any detectable beneficial response.
Our failure to recover adenovirus from conjunctival scrapings 9 to I I days after the onset of symptoms in either treated or control groups would suggest that adenovirus is rapidly eliminated after infection. At this time, however, in many patients, there was still active progression of keratitis which might indicate that this manifestation may be wholly or partially due to an antigen-antibody reaction.
Summary
A double-blind trial was carried out on the use of o05 per cent. 5-iodo-2'-deoxyuridine, in ointment form, in the treatment of 35 out-patients with virologically proven adenovirus infection of the eye. The adenovirus infections pursued a typical course uninfluenced by treatment with IDU.
